Darryl LeSueur

Darryl LeSueur serves as a key procurement lead within W40M MRCO Pacific, a U.S. Army organization responsible for sustaining advanced medical capabilities across the Indo-Pacific theater. He manages the acquisition of critical biomedical infrastructure, including in-vitro diagnostic systems, surgical instrumentation, and electromedical equipment essential to military treatment facilities. His role centers on ensuring operational readiness through timely, compliant, and technically sound contracting actions that align with the Department of the Army’s mission to maintain high-functioning clinical environments in austere and deployed settings. LeSueur routinely oversees complex, high-stakes procurements requiring strict adherence to federal acquisition regulations and medical device standards. He maintains consistent, long-term relationships with leading biomedical suppliers including Roche Diagnostics Corporation, BioFire Defense LLC, Siemens Healthcare Diagnostics Inc., Jupiter Logix Inc., and Kundo Enterprise Co., Ltd. These partnerships reflect a preference for established vendors with proven capabilities in clinical diagnostics, molecular detection systems, and integrated laboratory automation. His contracting approach emphasizes performance-based outcomes, technical validation, and supply chain resilience, often resulting in multi-year indefinite-delivery/indefinite-quantity (IDIQ) or blanket purchase agreement (BPA) structures that ensure continuity of critical medical services. LeSueur’s procurement portfolio reflects a strict focus on full and open competition, with 100% of awards issued under no set-aside preferences. There is no current reliance on 8(a), HUBZone, SDVOSB, or other socioeconomic programs, indicating a mission-driven prioritization of technical capability and operational reliability over socioeconomic targeting. His primary expertise lies within NAICS 325413—In-Vitro Diagnostic Substance Manufacturing—where he procures advanced diagnostic reagents, automated analyzers, point-of-care testing platforms, and associated calibration and maintenance services. This specialization underscores his deep technical fluency in clinical laboratory systems and infectious disease detection technologies critical to force health protection.